TELA BIO INC. - COMMON STOCK

TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization

14 Feb 2023 04:00:00 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

20 Jan 2023 13:05:00 By Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds

09 Jan 2023 04:00:01 By Nasdaq GlobeNewswire

TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference

21 Dec 2022 04:00:00 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 Dec 2022 13:02:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference

21 Nov 2022 04:00:00 By Nasdaq GlobeNewswire

TELA Bio Reports Third Quarter 2022 Financial Results

09 Nov 2022 13:01:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum

03 Nov 2022 04:00:02 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 Oct 2022 13:05:00 By Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2022 Financial Results

27 Oct 2022 04:00:01 By Nasdaq GlobeNewswire

TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair

26 Oct 2022 04:00:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Investor Conferences

01 Sep 2022 04:00:01 By Nasdaq GlobeNewswire

TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase

23 Aug 2022 13:01:00 By Nasdaq GlobeNewswire

TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

18 Aug 2022 13:01:00 By Nasdaq GlobeNewswire

TELA Bio Announces Pricing of Public Offering of Common Stock

15 Aug 2022 19:20:00 By Nasdaq GlobeNewswire

TELA Bio Announces Proposed Public Offering of Common Stock

15 Aug 2022 13:01:00 By Nasdaq GlobeNewswire

TELA Bio Reports Second Quarter 2022 Financial Results

10 Aug 2022 13:01:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Investor Conferences

05 Aug 2022 04:00:00 By Nasdaq GlobeNewswire

TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repairs; Data to Be Presented at 2022 American Hernia Society (AHS) Meeting

04 Aug 2022 04:00:02 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29 Jul 2022 13:01:00 By Nasdaq GlobeNewswire